Menu
Menu
The composition of NervGen’s Board and Committees are as follows:
* indicates independent non-executive board member
| Director | Board | Audit | Compensation | Nominating and Corporate Governance | Science |
|---|---|---|---|---|---|
| Bill Radvak |  |
Observer | |||
| Brian Bayley* |  |
|
|
|
|
| Paul Brennan | |
Observer | |||
| Glenn Ives* | |
|
|
||
| Randall Kaye* | |
|
|
||
| Krista McKerracher* | |
|
|
|
|
| Harold Punnett* | |
|
|
||
| Adam Rogers* | |
||||
| Craig Thompson* | |
NervGen (TSX-V: NGEN, OTCQX: NGENF) is a clinical stage biotech company dedicated to developing innovative treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company’s initial focus is on Alzheimer’s, spinal cord injury and multiple sclerosis.
Contact
2955 Virtual Way
Suite 480
Vancouver, BC V5M 4X6
Phone: (778) 731-1711
Email: info@nervgen.com